SKYSCRAPER-07: A phase III, randomized, double-blind, placebo-controlled study of atezolizumab with or without tiragolumab in patients with unresectable ESCC who have not progressed following definitive concurrent chemoradiotherapy

Karyn A. Goodman; Rui-hua Xu; Ian Chau; Ming Huang Chen; Byoung Chul Cho; Manish A. Shah; Kei Muro; Yifan Wang; Mari Ichimaru; Qingyuan Liu; Luhua Wang

doi:10.1200/JCO.2022.40.4_suppl.TPS374

YUHSpace

BROWSE

0 269

Cited 0 times in

SKYSCRAPER-07: A phase III, randomized, double-blind, placebo-controlled study of atezolizumab with or without tiragolumab in patients with unresectable ESCC who have not progressed following definitive concurrent chemoradiotherapy

Authors: Karyn A. Goodman ; Rui-hua Xu ; Ian Chau ; Ming Huang Chen ; Byoung Chul Cho ; Manish A. Shah ; Kei Muro ; Yifan Wang ; Mari Ichimaru ; Qingyuan Liu ; Luhua Wang